Suggested Statistical Reporting Guidelines for Clinical Trials Data
نویسندگان
چکیده
منابع مشابه
Ethical Guidelines for Internal Audit Reporting Lines
The present study identifies ethical ways of auditing reporting, which define the relationship between internal audit and the various authorities of the organization. Defining these lines as determinants of impartiality and independence of internal audit is of great importance. In this research, the structural equation model has been used to test the proposed model. The information required for...
متن کاملGuidelines for reporting embedded recruitment trials
BACKGROUND Recruitment to clinical trials is difficult with many trials failing to recruit to target and within time. Embedding trials of recruitment interventions within host trials may provide a successful way to improve this. There are no guidelines for reporting such embedded methodology trials. As part of the Medical Research Council funded Systematic Techniques for Assisting Recruitment t...
متن کاملDeveloping guidelines for reporting embedded recruitment trials
The problem Recruitment to clinical trials is problematic with many failing to recruit to target and within time. Embedding recruitment trials within effectiveness trials may provide a successful way to improve this. There are no guidelines for reporting such embedded trials. As part of the Systematic Techniques for Assisting Recruitment to Trials (START) project designed to test interventions ...
متن کاملReporting of clinical trials: a review of research funders' guidelines
BACKGROUND Randomised controlled trials (RCTs) represent the gold standard methodological design to evaluate the effectiveness of an intervention in humans but they are subject to bias, including study publication bias and outcome reporting bias. National and international organisations and charities give recommendations for good research practice in relation to RCTs but to date no review of th...
متن کاملUpdated methods for reporting clinical trials.
The reporting of early clinical trials is in evolution. As new drugs that target molecules that are selectively altered in cancer cells become available, much more will be expected from early trials than was expected in the past. Our concept of phase I trials that only determine maximum tolerated dose and recommended phase II dose of a drug will be replaced by different endpoints. These will in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Psychological Medicine
سال: 2012
ISSN: 0253-7176,0975-1564
DOI: 10.4103/0253-7176.96152